SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-143419
Filing Date
2024-05-21
Accepted
2024-05-21 09:15:30
Documents
13
Period of Report
2024-05-16
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d612188d8k.htm   iXBRL 8-K 26410
  Complete submission text file 0001193125-24-143419.txt   150061

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lyra-20240516.xsd EX-101.SCH 2866
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lyra-20240516_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lyra-20240516_pre.xml EX-101.PRE 11269
16 EXTRACTED XBRL INSTANCE DOCUMENT d612188d8k_htm.xml XML 3626
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 24967068
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)